Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes

被引:27
作者
Flannery, Patrick J.
Spurney, Robert F.
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA
[2] Durham VA Med Ctr, Durham, NC USA
来源
NEPHRON EXPERIMENTAL NEPHROLOGY | 2006年 / 103卷 / 03期
关键词
angiotensin II; epidermal growth factor receptor; extracellular signal-regulated kinase; matrix metalloproteases; podocyte; transactivation;
D O I
10.1159/000092196
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Activation of angiotensin II (ANG2) receptors stimulates extracellular signal-regulated kinases (ERKs) that, in some cell systems, are mediated by transactivating the epidermal growth factor (EGF) receptor (EGFR) through mechanisms involving matrix metalloprotease (MMP)-stimulated processing of heparin-binding EGF (HB-EGF) from its precursor. Methods: The signaling pathways linked to ANG2-dependent ERK activation were determined in an immortalized mouse podocyte cell line by monitoring ANG2-stimulated phosphorylation of ERK1/2. Results: ANG2 induced transient ERK phosphorylation that was maximal at 5 min and then rapidly dissipated. ANG2-dependent ERK activation was inhibited by: (1) the type-1 ANG2-selective antagonist losartan; (2) the type-2 ANG2-selective antagonist PD123319; (3) an inhibitor of MMP2/9; (4) the EGFR kinase inhibitor AG1478, and (5) the HB-EGF antagonists CRM197 and heparin. ANG2-dependent ERK activation was mediated by both protein kinase C (PKC)- and calcium-dependent mechanisms and was associated with tyrosine phosphorylation of EGFR. To determine if ANG2-dependent HB-EGF release could act in a paracrine fashion on adjacent cells, HEK293 cells were stably transfected with green fluorescent protein-tagged ERK2 (GFP-ERK2). In stably transfected HEK293 cells, EGF stimulated phosphorylation of endogenous ERK1/2 as well as GFP-ERK2. In contrast, ANG2 had no effect on ERK phosphorylation in stably transfected HEK293 cells. When poclocytes were co-cultured with stably transfected HEK293 cells, however, treatment with ANG2 rapidly stimulated GFP-ERK2 phosphorylation. Both the MMP2/9 inhibitor and AG1478 attenuated ANG2-dependent phosphorylation of GFP-ERK2 in the co-culture system. Conclusions: These data indicate that ERK activation is induced by ANG2 in podocytes by mechanisms involving ANG2-dependent release of HB-EGF which, in turn, may act in an autocrine and paracrine fashion to stimulate ERK activity.
引用
收藏
页码:E109 / E118
页数:10
相关论文
共 55 条
[1]   Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth [J].
Akishita, M ;
Ito, M ;
Lehtonen, YA ;
Daviet, L ;
Dzau, VJ ;
Horiuchi, M .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (01) :63-71
[2]   Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells [J].
Andresen, BT ;
Linnoila, JJ ;
Jackson, EK ;
Romero, GG .
HYPERTENSION, 2003, 41 (03) :781-786
[3]   Regression of renal vascular and glomerular fibrosis: Role of angiotensin II receptor antagonism and matrix metalloproteinases [J].
Boffa, JJ ;
Lu, Y ;
Placier, S ;
Stefanski, A ;
Dussaule, JC ;
Chatziantoniou, C .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (05) :1132-1144
[4]   Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy [J].
Booz, GW ;
Baker, KM .
HYPERTENSION, 1996, 28 (04) :635-640
[5]   SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1 [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
SPORN, MB ;
RUOSLAHTI, E .
NATURE, 1990, 346 (6282) :371-374
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[8]   CHARACTERIZATION OF THE ANGIOTENSIN-II AT(1) RECEPTOR SUBTYPE INVOLVED IN DNA-SYNTHESIS IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
BRIAND, V ;
RIVA, L ;
GALZIN, AM .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (04) :1195-1201
[9]   NOMENCLATURE FOR ANGIOTENSIN RECEPTORS - A REPORT OF THE NOMENCLATURE-COMMITTEE OF THE COUNCIL-FOR-HIGH-BLOOD-PRESSURE-RESEARCH [J].
BUMPUS, FM ;
CATT, KJ ;
CHIU, AT ;
DEGASPARO, M ;
GOODFRIEND, T ;
HUSAIN, A ;
PEACH, MJ ;
TAYLOR, DG ;
TIMMERMANS, PBMWM .
HYPERTENSION, 1991, 17 (05) :720-721
[10]  
Burns GC, 1997, J AM SOC NEPHROL, V8, P1140